Sebastien G. St-Louis, a Senior Officer, disposed of 115,998 Common Shares on a direct ownership basis at a price of $3.806 on March 5th, 2018. The insider also disposed of 400,002 Common Shares on an indirect ownership basis for registered holder 8375739 Canada Inc. at prices ranging from $3.806 to $3.962 between March 5th, 2018 and March 8th, 2018. This represents a $1,995,412 divestment of the company's shares and an account share holdings change of -70.2%.
Adam Miron, a Senior Officer and Director, disposed of 300,000 Common Shares on an indirect ownership basis for registered holder No. 2 Mission Row Inc. at prices ranging from $3.852 to $3.954 between March 6th, 2018 and March 8th, 2018. This represents a $1,170,710 divestment of the company's shares and an account share holdings change of -8.2%.
The Hydropothecary is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Hydropothecary Corp, formerly BFK Capital Corp, is a Canada-based company, which is an authorized licensed producer and distributor of medical marijuana under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company provides naturally and rigorously tested medical marijuana, grown without the use of synthetic pesticides in greenhouses. In addition to medical marijuana production and sales, the Company explores research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry. In addition, the Company is investigating the development and patenting of novel technologies related to medical marijuana, as well as the import and export of medical marijuana.
No Comments